To date, despite preclinical evidence revealing that genetic or pharmacological disruption of nNOS/NOS1AP interactions targeting an intermediate region of the dentate gyrus (and parts of CA3) has anxiolytic effects [13,[68], [69], [70]], there is no study linking NOS1AP to anxiety in humans. This evidence concerns the gene NOS1 and Anxiety.